Dedicated to primary cells
Product and service development

Dedicated to the development of primary cell products and services

Learn More
Primary Cells, Pharmacological Efficacy Services, and Product Services
One-Stop Expert in Upstream Cell Solutions

Expert in one-stop upstream cell solutions for primary cells, drug efficacy services, and product services

Learn More
Closing the Loop from Biospecimens to Products
Driving Innovation in Life Sciences

Closing the Loop from Biospecimens to Products — Driving Innovation in Life Sciences.

Learn More
scroll down

About Us

Dedicated to primary cells
Product and Service Development

Hycells Biotechnology Co., Ltd. is an innovative biotechnology company specializing in primary cells, related reagents, and technical services. With a long-standing commitment to the fields of cell and gene therapy (CGT) and large-molecule therapeutics, the team is dedicated to providing customers with end-to-end, one-stop solutions for primary cell products—covering research and development, manufacturing, sales, and technical support.

View more

Product Center

Quality first, innovation oriented

Cultivation Products

.

Culture products generally refer to various reagents, consumables and equipment used for in vitro culture, expansion and maintenance of cells, and are widely used in scientific research, drug development, vaccine production, cell therapy and other fields.

Obtain Solutions →

Testing Products

.

Hycells is committed to becoming a leading global one-stop supplier of primary cells, related reagents, and services.

Obtain Solutions →

Other Products And Instruments

.

Hycells is committed to becoming a leading global one-stop supplier of primary cells, related reagents, and services.

Obtain Solutions →

Cultivation Products

Cultivation Products

Testing Products

Testing Products

Other Products And Instruments

Other Products And Instruments

Our Advantages

Primary Cells, Pharmacological Efficacy Services, and Product Services
One-Stop Expert in Upstream Cell Solutions

Quality

High-quality technical standards

Professional

Professional laboratory research team

Compliance

Clinical Sample Collection Compliance System

After-sales

A comprehensive after-sales service system

News Updates

Stay updated on He Yousheng’s latest news

Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.

This article will examine how He Yousheng proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.

In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.

Recently, the research team led by Researcher Bian Yingjie at the Guangzhou National Laboratory, in collaboration with partners from Sun Yat-sen University, published a study titled “Iron overload in the tumor microenvironment induces CD8⁺ T cell ferroptosis and dysfunction” in the internationally renowned academic journal Nature Communications.

The company consistently upholds its core values of “people‑centricity, quality first, and innovation as the foundation,” remains driven by technological innovation, and sets new industry benchmarks for domestic innovation, thereby laying a solid foundation for the development and global advancement of China’s innovative pharmaceutical sector.

The HiXpan® NK Serum-Free Culture Kit, Version 3.0, is manufactured in strict compliance with GMP standards, and its production system fully adheres to relevant guidelines and regulations, including the “818 Requirements,” positioning it for pharmaceutical‑grade manufacturing and applications.

Quickly access products and solutions

Currently, Heyousheng has established nearly 1,000 square meters of R&D laboratories and has officially obtained GB/T 19001-2016/ISO 9001:2015 quality management system certification. The company has also been recognized as a “Shanghai High-Tech Enterprise” and a “Shanghai Specialized, Sophisticated, Distinctive, and Innovative SME.” Heyousheng is committed to becoming a world-leading one-stop supplier of primary cells, associated reagents, and related services.